Medical News

RSS

First Edition: June 18, 2012

Today's headlines include reports on the upcoming Supreme Court health law decision and the politics of health policy.

18 Jun 2012

Illumina's new patent infringement suit targets Complete Genomics' cPal read technology

Illumina (NASDAQ:ILMN) announced today that the company has filed an additional patent infringement suit against Complete Genomics, Inc. Illumina is seeking all available remedies, including injunctive relief.

From Illumina, Inc. 18 Jun 2012

Multi-year initiative to help people live longer and better

With 10,000 Americans turning 65 every day - and according to new research released today, a majority of them expect to live to nearly 90 - the celebration of older Americans is a developing trend, and more people are aspiring to live longer and better than ever before.

18 Jun 2012

Concord Medical acquires 52% equity ownership in Chang'an Hospital

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, announced today that it has closed the acquisition of 52% equity ownership in Chang'an Hospital, a leading non-public general hospital located in Xi'an, Shaanxi Province.

18 Jun 2012

CMC Biologics' Bothell manufacturing and testing facilities receive cGMP compliance

CMC Biologics, a leading contract manufacturing organization (CMO) known for its technical excellence in process development and cGMP manufacture, has received a Certificate of Good Manufacturing Practice (GMP) Compliance for commercial manufacturing issued by the Medicines and Healthcare products Regulatory Agency (MHRA).

18 Jun 2012

Ambrx, Merck collaborate to develop and commercialize biotherapeutic drug conjugates

Ambrx today announced that the company has entered into a collaboration with Merck to design and develop rationally optimized biologic drug conjugates based on Ambrx's site-specific protein medicinal chemistry technology.

18 Jun 2012

Cancer publishes Aeterna Zentaris' perifosine Phase 2 trials in RCC

Aeterna Zentaris Inc. today announced that data from two Phase 2 trials in renal cell carcinoma (RCC) for the Company's oral anticancer drug, perifosine, have been published in the June 2012 issue of Cancer, a publication of the American Cancer Society.

18 Jun 2012

Agility MLC's new design provides better dose sculpting capabilities

Requiring only a quick upgrade to their existing Elekta Synergy linear accelerator, physicians at SALK and Paracelsus Medical University began using the new Agility 160-leaf multileaf collimator (MLC), treating 33 patients on its first day. In its first month of Agility use, the center now treats 50 patients per day, comprising about 700 individual treatment sessions that have benefited from this breakthrough in cancer care.

From Elekta 18 Jun 2012

EAACI launches Food Allergy Campaign

Today the European Academy of Allergy and Clinical Immunology (EAACI) launched its Food Allergy Campaign. The purpose of the campaign is to raise awareness of the sharp increase of anaphylaxis in children, an allergic reaction that is severe and potentially life-threatening. It aims at educating the public to recognise the symptoms and its triggers, and to teach methods of how to react in case of emergency, e.g. by using an adrenaline pen.

18 Jun 2012

Lower dose study using Toshiba AIDR 3D with Aquilion ONE CT system

Today's healthcare facilities seek to manage patient radiation dose while maintaining high image quality for accurate diagnoses. Dr. Jeff Dardinger from St. Elizabeth Healthcare in Edgewood, Ky., will discuss the initial findings of using Toshiba's AIDR 3D with the AquilionTM ONE CT system to lower dose while maintaining high image quality across multiple CT exams.

18 Jun 2012

Spectros introduces OnCall wireless remote access to view real-time patient results

Spectros Corporation announces the successful launch of OnCall wireless remote access for viewing real-time patient results on T-Stat white light tissue oximeters.

18 Jun 2012

Is curry good for you?

There have been several news stories over the years reporting that curry may be good for us. Most of them refer to a chemical in curry, known as curcumin.

18 Jun 2012

Ascepion, Debiopharm partner to develop and commercialize ASP-08126 for solid tumors

Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Ascepion Pharmaceuticals, Inc., a privately-held, biopharmaceutical company dedicated to the discovery and development of breakthrough small molecule drugs for the treatment of oncology and related diseases, have entered into an exclusive worldwide license agreement concerning the development and commercialization of ASP-08126 (called Debio 1144 by Debiopharm) a multikinase inhibitor currently in pre-clinical development.

18 Jun 2012

Updated data from ARIAD’s ponatinib pivotal trial on CML or Ph+ ALL

ARIAD Pharmaceuticals, Inc. today announced updated clinical data from the pivotal PACE trial of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with chronic myeloid leukaemia (CML) or Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL), who are resistant or intolerant to dasatinib or nilotinib or who have the T315I mutation.

18 Jun 2012

First study to look at hotel room cleanliness

An experiment of surfaces in hotel rooms finds television remotes to be among the most heavily contaminated with bacteria and items on housekeeping carts carry the potential to cross-contaminate rooms. Researchers from the University of Houston report the findings today at the 2012 General Meeting of the American Society for Microbiology.

18 Jun 2012

NHS Supply Chain signs deal to purchase 10 Elekta Synergy radiation therapy treatment systems

NHS Supply Chain will bring state-of-the-art cancer treatment to the United Kingdom by signing a deal to purchase ten Elekta Synergy radiation therapy treatment systems.

From Elekta 18 Jun 2012

Quintiles announces agreements to expand lab testing capabilities in China

In a ceremony underscoring the growing importance of China to the global biopharmaceutical industry, Quintiles executives and local dignitaries today announced agreements to establish a Quintiles regional headquarters for China in Shanghai and to significantly expand lab testing capabilities in China.

18 Jun 2012

DBV Technologies’ Viaskin safe and effective in treating children with peanut allergy

DBV Technologies, creator of Viaskin, a new standard in the treatment of allergy, announced today that AP-HP (Assistance Public - Hôpitaux de Paris) sponsor of the ARACHILD study presented at the EAACI Congress a late breaking oral presentation on safety and efficacy data after six months of epicutaneous immunotherapy in peanut allergy using Viaskin Peanut.

18 Jun 2012

FDA completes review of compounded hydroxyprogesterone caproate products and APIs

FDA (or the Agency) approved Makena (hydroxyprogesterone caproate) in February 2011 for the reduction of the risk of certain preterm births in women who have had at least one prior preterm birth. Beginning many years before Makena was approved, a version of the active ingredient of Makena has been available to patients whose physicians requested the drug from a pharmacist who compounded the drug.

18 Jun 2012

WHO launches new tool to improve quality and human rights in mental health and social care

WHO urges countries to protect the rights and dignity of people with mental health conditions as it launches a new tool for countries to assess and eventually stop, these violations. The WHO QualityRights Tool Kit aims to ensure that quality of care and human rights standards are put in place in mental health and social care facilities around the world.

18 Jun 2012

Medical News

First Edition: June 18, 2012

Illumina's new patent infringement suit targets Complete Genomics' cPal read technology

Multi-year initiative to help people live longer and better

Concord Medical acquires 52% equity ownership in Chang'an Hospital

CMC Biologics' Bothell manufacturing and testing facilities receive cGMP compliance

Ambrx, Merck collaborate to develop and commercialize biotherapeutic drug conjugates

Cancer publishes Aeterna Zentaris' perifosine Phase 2 trials in RCC

Agility MLC's new design provides better dose sculpting capabilities

EAACI launches Food Allergy Campaign

Lower dose study using Toshiba AIDR 3D with Aquilion ONE CT system

Spectros introduces OnCall wireless remote access to view real-time patient results

Is curry good for you?

Ascepion, Debiopharm partner to develop and commercialize ASP-08126 for solid tumors

Updated data from ARIAD’s ponatinib pivotal trial on CML or Ph+ ALL

First study to look at hotel room cleanliness

NHS Supply Chain signs deal to purchase 10 Elekta Synergy radiation therapy treatment systems

Quintiles announces agreements to expand lab testing capabilities in China

DBV Technologies’ Viaskin safe and effective in treating children with peanut allergy

FDA completes review of compounded hydroxyprogesterone caproate products and APIs

WHO launches new tool to improve quality and human rights in mental health and social care

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News